Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 607 of 1,261
  1. US 9770452

    Quinoxaline derivatives as GPR6 modulators

    Takeda Pharmaceutical Company Limited · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  2. US 9770456

    Compositions comprising acidic extracts of mastic gum

    REGENERA PHARMA LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  3. US 9770450

    4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139

    Takeda Pharmaceutical Company Limited · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  4. US 9770433

    Composition and method for treating tinnitus

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  5. US 9770405

    Biocompatible capsules and methods of making

    The United States of America as represented by the Administrator of NASA · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  6. US 9770414

    Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

    Pacira Pharmaceuticals, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  7. US 9770412

    Implant device for drug delivery

    Nano Precision Medical, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  8. US 9765139

    Perfusion method for manufacturing etanercept

    Coherus BioSciences, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  9. US 9765123

    Pseudomonas exotoxin a with less immunogenic T cell and/or B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  10. US 9765340

    RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders

    Arrowhead Pharmaceuticals, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  11. US 9765091

    Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  12. US 9765119

    Cyclosporine analogue mixtures and their use as immunomodulating agents

    AURINIA PHARMACEUTICALS INC. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  13. US 9765147

    Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer

    Five Prime Therapeutics, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  14. US 9765337

    Phosphoribosyl pyrophosphate synthetase 2 (PRPS2) as a therapeutic target in cancer treatment

    The Regents of the University of California · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  15. US 9765063

    Amido compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  16. US 9765028

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  17. US 9765055

    Intramolecular hydrogen-bonded nitric oxide synthase inhibitors

    Northwestern University · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  18. US 9765047

    Process for making beraprost

    United Therapeutics Corporation · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  19. US 9765043

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  20. US 9765031

    Cannabinoid receptor mediating compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  21. US 9764036

    Lipids and compositions for the delivery of therapeutics

    ARBUTUS BIOPHARMA CORPORATION · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  22. US 9764039

    Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  23. US 9764065

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  24. US 9764022

    Methods and compositions for inhibiting polyomavirus-associated pathology

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.